Skip to main content
PREVIEW · SAMPLE DATA
This is the RAPP dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for RAPP.

RAPP

Rapport Therapeutics, Inc.
Healthcare · Biotechnology
$192.04 sample
-0.92 (-0.48%) 1D
☆ Watch
Market cap
$764.3B
Price as of
2026-10-29
Latest filing
8-K
Alerts
8
Price$192.04 -6.31% 3M daily closessample
226.74192.04
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 27INSInsider sell: Director
  • Oct 21INSInsider sell: Director
  • Oct 13INSInsider sell: General Counsel
  • Oct 08INSInsider sell: Director
  • Sep 30INSInsider sell: Director
  • Sep 23INSInsider sell: EVP, Operations
  • Sep 18INSInsider sell: Director
  • Sep 09INSInsider buy: 10% owner
Sign up to see the real RAPP record →

Company facts

SEC EDGAR registration
Name
Rapport Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+12sample, -100 to +100
Reporting currency
USD

Who is positioning in RAPP

sample
Insiders
11 insider transactions over 90 days, net selling, $549.3M
Congress
3 members traded over 90 days
Institutions · 13F
34 funds hold $4.2B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$25.9B +16.8% y/y
Q4 2024Q3 2026
Inventory$14.9B +11.1% y/y
Q4 2024Q3 2026
Accounts receivable$11.0B +8.7% y/y
Q4 2024Q3 2026
Total debt$30.3B +17.9% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$433.8B +14.5% 3M
Sample peer B
$501.5B +13.8% 3M
Sample peer C
$522.1B +0.9% 3M
Sample peer D
$706.0B +4.7% 3M
Sample peer E
$724.3B +3.4% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not RAPP's real figure. Nothing here is investment advice.